30th April 2020 Overnight Market Wrap

30th April 2020 Overnight Market Wrap

 Key Points

  • U.S. stocks rise on Powell comments and positive news from Gilead
  • Fed’s Powell vows a strong and protracted fight to offset Corona Virus
  • U.S. GDP falls 4.8% in Q1

Bias: Risk on (tentatively)


U.S. stocks bounced nicely overnight, supported by comments from Fed President Powell vowing a strong and protracted fight to offset the Corona Virus fallout. Also supporting was a report from Gilead that its clinical trial for its Corona Virus drug met the study’s goals. The market largely shrugged of a 4.8% fall in U.S. GDP in Q1.

The Big Dollar was broadly weaker, but within tight ranges, as players continued to look for slightly higher risk plays. This saw buying in the Euro, Cable. USD/JPY help its tight recent range, while The AUD was slightly firmer.

Gold and oil prices were slightly firmer, supported by Powell’s comments but mostly dominated by position adjustment flows.


Today may be interesting in Asia, with players eyeing a slew of data and with prices building within tight recent ranges on currencies. The main data release is Chinese PMI, while Japanese Consumer Confidence and Housing Starts are also slated. Tonight sees Euro-zone GDP and CPI along with U.S. Chicago PMI.

Trade the global markets with a broker that has integrity, honesty and transparency at its core


This website is owned and operated by the Ox Securities group of companies, which include:
Ox Securities Pty Ltd registered address Level 37, 1 Macquarie Place, Sydney NSW 2000 Australia. AFSL 438402 ACN 163 551 602
Ox Securities Limited (SV) registered address Suite 305, Griffith Corporate Centre, Beachmont, Kingstown, St Vincent and the Grenadines
Risk Warning: The information contained on this website is general in nature and does not constitute advice or a recommendation to act upon the information or an offer. The information on this website does not take into account your personal objectives, circumstances, financial situations or needs. You are strongly recommended to seek independent professional advice before opening an account with us and/or acquiring our services/products. Ox Securities Limited (SV) do not accept applications from residents of the United States of America and Australia
Before you decide whether or not to invest any products referred to on this website, being over the counter (OTC) derivatives, it is important for you to read and consider our Financial Services Guide (FSG), Product Disclosure Statement (PDS), and Terms and Conditions (T&C), and ensure that you fully understand the risks involved. Fees, charges and commissions apply. OTC derivatives, including margin foreign exchange contracts and contract for differences, are leveraged products that carry a high level of risk to your capital. Trading is not suitable for everyone. You may incur losses that are substantially greater than your initial investment. You do not own, or have any rights to, the underlying assets which the OTC derivative is referring to. You should only trade with money you can afford to lose. There are also risks associated with online trading including, but not limited to, hardware and/or software failures, and disruptions to communication systems and internet connectivity.

Copyright © OxSecurities 2020. All rights reserved